Ifosfamide Injection, Powder, For Solution
Product Images NDC 10019-927

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ifosfamide (NDC 10019-927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ifosfamide Novaplus Structural Formula (Image 01)

FDA Label Image

Novaplus Logo (Image 02)

FDA Label Image

Representative Ifosfamide Novaplus Container Label 10019-927-20 (Image 03)

Representative Ifosfamide Novaplus Container Label 10019-927-20 (Image 03)
This is a vial containing 1 g fosfamide, which requires the addition of 20mL Sterile Water for Injection or Sterile Bacteriostatic Water for Injection containing benzyl alcohol or parabens preservatives. After shaking to dissolve, the concentration obtained will be 50mg per mL. It is recommended to store at a controlled room temperature of 20°C to 25°C, avoiding temperatures above 30°C. Baxter Healthcare Corporation manufactured it for intravenous use. Please refer to the package insert for detailed indications, dosage, and precautions. Novaplus is a registered trademark of Vizient, Inc.*
FDA Label Image

Representative Ifosfamide Novaplus Carton Label 10019-927-01 (Image 04)

FDA Label Image

Representative Ifosfamide Novaplus Container Label 10019-929-60 (Image 05)

Representative Ifosfamide Novaplus Container Label 10019-929-60 (Image 05)
This is a description for a medication called Ifosfamide for Injection. The medication comes in a single-dose vial with a specific identification code. To prepare the medication for intravenous (IV) use, 3 grams of the vial needs to be added to 60 ml of sterile water or sterile bacteriostatic water. The reconstituted concentration should be 50 mg per ml. The medication should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), and should be protected from temperatures above 30°C (86°F). It's important to read the accompanying package insert for more detailed information about the medication, including indications, dosage, and precautions. The medication is manufactured by Barter Healthcare Corporation located in Deerfield, IL, USA.*
FDA Label Image

Representative Ifosfamide Novaplus Carton Label 10019-929-03 (Image 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.